{"id":"https://openalex.org/W2321375336","doi":"https://doi.org/10.1111/fcp.12169","title":"Safety profile of etifoxine: A French pharmacovigilance survey","display_name":"Safety profile of etifoxine: A French pharmacovigilance survey","publication_year":2015,"publication_date":"2015-11-20","ids":{"openalex":"https://openalex.org/W2321375336","doi":"https://doi.org/10.1111/fcp.12169","mag":"2321375336","pmid":"https://pubmed.ncbi.nlm.nih.gov/26588183"},"language":"en","primary_location":{"id":"doi:10.1111/fcp.12169","doi":"https://doi.org/10.1111/fcp.12169","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12169","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079618593","display_name":"Judith Cottin","orcid":"https://orcid.org/0000-0002-5037-126X","observed_orcids":["https://orcid.org/0000-0002-5037-126X"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Judith Cottin","raw_affiliation_strings":["Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085014425","display_name":"Aurore Gouraud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurore Gouraud","raw_affiliation_strings":["Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088808508","display_name":"M.-J. Jean-Pastor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]},{"id":"https://openalex.org/I4210134195","display_name":"H\u00f4pital Sainte-Marguerite","ror":"https://ror.org/0338wkj94","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie\u2010Jos\u00e8phe Jean\u2010Pastor","raw_affiliation_strings":["Regional Pharmacovigilance Center of Marseille H\u00f4pital Sainte\u2010Marguerite, University Hospitals (AP\u2010HM), 270 Boulevard de Sainte\u2010Marguerite 13274 Marseille Cedex 09 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Marseille H\u00f4pital Sainte\u2010Marguerite, University Hospitals (AP\u2010HM), 270 Boulevard de Sainte\u2010Marguerite 13274 Marseille Cedex 09 France","institution_ids":["https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026425946","display_name":"Anne Dautriche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116240","display_name":"CHU Dijon Bourgogne","ror":"https://ror.org/0377z4z10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116240"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Disson\u2010 Dautriche","raw_affiliation_strings":["Regional Pharmacovigilance Center of Dijon, University Hospitals, 14 rue Paul Gaffarel, 21079 Dijon Cedex, BP 779008, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Dijon, University Hospitals, 14 rue Paul Gaffarel, 21079 Dijon Cedex, BP 779008, France","institution_ids":["https://openalex.org/I4210116240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068020671","display_name":"Charl\u00e8ne Boulay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charl\u00e8ne Boulay","raw_affiliation_strings":["Regional Pharmacovigilance Center of Rouen, University Hospitals, Service de pharmacologie, 76 031 Rouen Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Rouen, University Hospitals, Service de pharmacologie, 76 031 Rouen Cedex, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090076726","display_name":"H\u00e9l\u00e8ne Geniaux","orcid":"https://orcid.org/0000-0003-1447-8534","observed_orcids":["https://orcid.org/0000-0003-1447-8534"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210112727","display_name":"H\u00f4pital Pellegrin","ror":"https://ror.org/02x581406","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H\u00e9l\u00e8ne Geniaux","raw_affiliation_strings":["Regional Pharmacovigilance Center of Bordeaux University Hospitals H\u00f4pital Pellegrin, 33076 Bordeaux Cedex France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Bordeaux University Hospitals H\u00f4pital Pellegrin, 33076 Bordeaux Cedex France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019416357","display_name":"Marine Auffret","orcid":"https://orcid.org/0000-0002-5236-9083","observed_orcids":["https://orcid.org/0000-0002-5236-9083","https://orcid.org/0000-0002-6739-6842"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marine Auffret","raw_affiliation_strings":["Regional Pharmacovigilance Center of Lille, University Hospitals, 1 Place de Verdun, 59045 Lille Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Lille, University Hospitals, 1 Place de Verdun, 59045 Lille Cedex, France","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102850613","display_name":"Nathalie Bernard","orcid":"https://orcid.org/0009-0003-8284-5479","observed_orcids":["https://orcid.org/0009-0003-8284-5479"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Bernard","raw_affiliation_strings":["Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109902824","display_name":"Jacques Descotes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacques Descotes","raw_affiliation_strings":["Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073932439","display_name":"Thierry Vial","orcid":"https://orcid.org/0000-0003-3786-581X","observed_orcids":["https://orcid.org/0000-0003-3786-581X"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thierry Vial","raw_affiliation_strings":["Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Pharmacovigilance Center of Lyon, University Hospitals, 162 avenue Lacassagne, 69003, Lyon, France","institution_ids":["https://openalex.org/I4210100596"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5079618593"],"corresponding_institution_ids":["https://openalex.org/I4210100596"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":1.7591,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.82930385,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"30","issue":"2","first_page":"147","last_page":"152"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etifoxine","display_name":"etifoxine","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.824999988079071},{"id":"https://openalex.org/keywords/benzoxazine-derivatives","display_name":"benzoxazine derivatives","score":0.6140000224113464},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.578000009059906},{"id":"https://openalex.org/keywords/drug-reaction-with-eosinophilia-and-systemic-symptoms","display_name":"DRESS syndrome","score":0.6660000085830688},{"id":"https://openalex.org/keywords/erythema-multiforme","display_name":"erythema multiforme","score":0.8980000019073486},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9929999709129333},{"id":"https://openalex.org/keywords/serum-sickness-like-reaction","display_name":"serum sickness-like reaction","score":0.8270000219345093},{"id":"https://openalex.org/keywords/vasculitis","display_name":"vasculitis","score":0.9210000038146973},{"id":"https://openalex.org/keywords/acute-hepatitis","display_name":"acute hepatitis","score":0.6100000143051147},{"id":"https://openalex.org/keywords/cytolytic-hepatitis","display_name":"cytolytic hepatitis","score":0.7289999723434448},{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.4390000104904175},{"id":"https://openalex.org/keywords/drug-induced-skin-reaction","display_name":"drug-induced skin reaction","score":0.5429999828338623},{"id":"https://openalex.org/keywords/microscopic-colitis","display_name":"microscopic colitis","score":0.800000011920929},{"id":"https://openalex.org/keywords/intermenstrual-bleeding","display_name":"metrorrhagia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8406239748001099},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7721605896949768},{"id":"https://openalex.org/C2993280485","wikidata":"https://www.wikidata.org/wiki/Q5958765","display_name":"Hypersensitivity reaction","level":2,"score":0.5448995232582092},{"id":"https://openalex.org/C2781320243","wikidata":"https://www.wikidata.org/wiki/Q1363732","display_name":"Erythema multiforme","level":2,"score":0.4946436583995819},{"id":"https://openalex.org/C2779703309","wikidata":"https://www.wikidata.org/wiki/Q33121","display_name":"Serum sickness","level":3,"score":0.45043468475341797},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.4434693157672882},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.4208641052246094},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.40125057101249695},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.32029062509536743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3006056249141693},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2709616720676422},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2616646885871887},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23239263892173767},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/fcp.12169","doi":"https://doi.org/10.1111/fcp.12169","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12169","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:26588183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26588183","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W142227981","https://openalex.org/W1617516138","https://openalex.org/W1973301018","https://openalex.org/W1997834452","https://openalex.org/W2009890917","https://openalex.org/W2031792305","https://openalex.org/W2032739299","https://openalex.org/W2129719717","https://openalex.org/W2146090786","https://openalex.org/W2348528624","https://openalex.org/W4290221959","https://openalex.org/W4319053765"],"related_works":["https://openalex.org/W1997834452","https://openalex.org/W3106697513","https://openalex.org/W4244336178","https://openalex.org/W4292446922","https://openalex.org/W4312740435","https://openalex.org/W7221568493","https://openalex.org/W142227981","https://openalex.org/W7006498563","https://openalex.org/W2889588859","https://openalex.org/W4281391562"],"abstract_inverted_index":{"Etifoxine":[0],"chlorhydrate":[1],"is":[2],"a":[3,168,215],"benzoxazine":[4],"derivative":[5],"approved":[6],"for":[7,93,207],"the":[8,61,76,89,106,138,235,240],"treatment":[9],"of":[10,13,120,148,161,181,191,195,217,234,239],"psychosomatic":[11],"manifestations":[12],"anxiety":[14],"since":[15],"1979.":[16],"Previously":[17],"labeled":[18],"adverse":[19],"drug":[20,141],"reactions":[21,104],"(ADRs)":[22],"only":[23],"include":[24],"drowsiness,":[25],"benign":[26],"cutaneous":[27,113],"reactions,":[28],"and":[29,73,130,145,188,219,227],"acute":[30,102,165,228],"hypersensitivity":[31,103],"reactions.":[32],"The":[33],"objectives":[34],"were":[35,58,85,97,105,117,156],"to":[36,69,81],"examine":[37],"recent":[38,232],"data":[39,74],"on":[40,246],"etifoxine-related":[41],"ADR":[42],"by":[43],"reviewing":[44],"Individual":[45],"Case":[46],"Safety":[47],"Reports":[48],"(ICSRs)":[49],"recorded":[50],"in":[51,124,128,133,142,158,172,186,223],"France":[52],"especially":[53],"unexpected":[54,175,218],"ADRs.":[55],"Etifoxine-related":[56],"ICSRs":[57],"extracted":[59],"from":[60,65,75],"French":[62,236],"Pharmacovigilance":[63],"database":[64],"1":[66],"January":[67],"2000":[68],"30":[70,210],"April":[71],"2012":[72],"marketing":[77],"authorization":[78],"holder":[79],"up":[80],"31":[82],"December":[83],"2011":[84],"also":[86],"obtained.":[87],"Of":[88],"350":[90],"cases":[91,119,147,180,190],"retained":[92],"analysis,":[94],"123":[95],"(35%)":[96],"considered":[98],"serious.":[99],"Dermatological":[100],"or":[101,150],"most":[107,139],"frequent":[108],"ADRs":[109,176],"(59%)":[110],"mainly":[111],"isolated":[112],"eruptions.":[114],"However,":[115],"there":[116],"24":[118],"severe":[121,225],"toxidermia":[122,226],"(DRESS":[123],"5,":[125,187],"erythema":[126],"multiforme":[127],"10":[129],"Stevens-Johnson":[131],"syndrome":[132],"5)":[134],"with":[135,167,183],"etifoxine":[136,200,203,237],"as":[137],"suspected":[140],"11":[143],"patients,":[144],"seven":[146],"vasculitis":[149],"serum":[151],"sickness-like":[152],"reaction.":[153],"Liver":[154],"disorders":[155],"reported":[157],"34":[159],"patients":[160],"whom":[162],"25":[163],"developed":[164],"hepatitis":[166],"cytolytic":[169,229],"biological":[170],"pattern":[171],"16.":[173],"Other":[174],"included":[177],"16":[178],"reversible":[179],"metrorrhagia":[182],"positive":[184],"rechallenge":[185],"three":[189],"biopsy-proven":[192],"microscopic":[193],"colitis":[194],"which":[196],"one":[197],"recurred":[198],"after":[199],"re-administration.":[201],"Although":[202],"has":[204],"been":[205],"marketed":[206],"more":[208],"than":[209],"years,":[211],"this":[212],"survey":[213],"identified":[214],"number":[216],"sometimes":[220],"serious":[221],"ADRs,":[222],"particularly":[224],"hepatitis.":[230],"A":[231],"update":[233],"summary":[238],"product":[241],"characteristics":[242],"(SPC)":[243],"was":[244],"based":[245],"these":[247],"findings.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}